Iridex ophthalmic laser system for glaucoma treatment receives CE Mark approval

Ophthalmology laser systems, delivery devices, and consumables maker Iridex (Mountain View, CA) has received its CE Mark to commercialize across Europe its Cyclo G6 laser system for use in treating glaucoma and its symptoms. The system is dedicated specifically to treating patients diagnosed with a range of glaucoma disease states, and features the company’s proprietary MicroPulse tissue-sparing technology and a family of single-use probes that connect to a laser console.

Iridex's Cyclo G6 laser system for use in treating glaucoma.

Dr. Keith Barton, Consultant Ophthalmologist, Glaucoma Service at Moorfields Eye Hospital (London, England) says that some studies that have used the Cyclo G6 system have shown a 30-40% reduction in intraocular pressure (IOP) without incisions or using implants.

The system will be sold with two disposable probes, the MicroPulse P3 probe for use with a broad range of glaucoma patients, and the G-Probe for later stage patients. The company plans to introduce a series of additional new probes in 2016 that allow for additional applications in glaucoma treatment.

For more information, please visit www.iridex.com.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS